Dr. Andrea Cercek is a researcher and medical oncologist at the prestigious Memorial Sloan Kettering Cancer Center in New York City. Dr. Cerek specializes in the treatment of patients with various gastrointestinal cancers, mainly colorectal and appendix cancers, in addition to the comprehensive treatment of those patients diagnosed with peritoneal mesothelioma. Cercek’s research is focused on the development of next-generation treatments for patients, including extensive research into molecular-based therapies as a form of treatment. In addition to her clinical and research work, Dr. Cerek also serves as an assistant professor of medicine in Joan and Sanford I. Weill Department of Medicine at the Weill Cornell Medical College in New York.
Depending on the needs of the patient, Cercek uses a combination of both systemic chemotherapy (the more traditional approach to cancer) and regional chemotherapy, in which the drugs are applied directly to the specific region needing therapy rather than the total region. For patients with peritoneal mesothelioma, for instance, regional chemotherapy would involve application of chemotherapy drugs to the peritoneal cavity. Regional chemotherapy has proven to be a very specific and proactive approach to attacking the various cancers that many patients respond very well to.
Dr. Cercek earned her medical degree in 2004 from New York Medical College and completed her residency at New York Presbyterian Hospital before moving on to Sloan-Kettering, where she currently resides. She is board certified in internal medicine as well as medical oncology.
As of early 2018, Cercek was leading a pair of clinical trials testing the effectiveness of various combinations of chemotherapy for the treatment of colorectal cancer. She also has worked as a co-investigator in several other clinical trials, most of them involving various types, combinations, and application methods of chemotherapy drugs and radiation therapy. One study in which she is involved compares the effectiveness of Pevonedistat (which inhibits a particular human protein) alone and in combination with chemotherapy for the treatment of patients with malignant mesothelioma. The results and effectiveness of that specific study are still ongoing.
Cercek’s contributions to cancer research have been published in a variety of esteemed medical journals, including the Journal of the American Medical Association’s Oncology publication, the Journal of Surgical Oncology, Cancer Cell, and the International Journal of Radiation Oncology.
Learn More About Mesothelioma
Asbestos Exposure Information
Did You Know?
Get Help from Experienced Mesothelioma Nurses
Learn more about these experienced mesothelioma nurses by watching the video below. Click here to contact a mesothelioma nurse now.
Learn More About MesoLawyersCare
Watch the video below to learn why MesoLawyersCare is the best choice to represent you and your family after a mesothelioma diagnosis.
Contact MesoLawyersCare Now
If you or a loved one has been diagnosed with mesothelioma, please contact us to see if we can help you get the compensation you deserve from the billions of dollars in asbestos trust funds available now for qualified asbestos victims. With just one call, you can put all our experience and success to work for you.
We have represented thousands of victims of mesothelioma and their families in virtually every State in the country and in decades of work have recovered billions of dollars in financial compensation for our clients.
Call us now at 1-888-568-1177, fill out the form on this page or chat with a live person. The consultation is free and it costs nothing upfront to hire the lawyers behind MesoLawyersCare. We only get paid if you collect a settlement or verdict and you will never receive a bill from us.